POM-V Prescription Required

GUMBOHATCH Lyophilisate and Solvent for Suspension for Injection

Active ingredient: Infectious bursal disease virus

Form

Injection

Species

Chickens

Manufacturer

Laboratorios Hipra SA

VMD MA No.

EU/2/19/245/001-007

What it's used for

Onset of immunity: ▪ ▪ ▪ Duration of immunity: ▪ ▪ Cross protection studies in the progeny showed a reduction in mortality and clinical signs of disease ca...

Full indications, dosage and side effects ↓

View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Infectious bursal disease vi...

1

Ask your vet for a written prescription

They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.
2

Fill it at a registered online retailer

The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Your prescription rights → VMD register of retailers →

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

GUMBOHATCH Lyophilisate and Solvent for Suspension for Injection — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

Onset of immunity:
▪
▪
▪
Duration of immunity:
▪
▪
Cross protection studies in the progeny showed a reduction in mortality and clinical
signs of disease caused by IBDV antigenic variant strains (variant E and GLS).
For ARV genotypes cross protection studies in the progeny showed the following:
•
genotype 2
•
•
for ARV genotype 5

be performed with live or inactivated vaccines against infectious bronchitis virus (e.g.,
Nobilis IB 4-91, Nobilis IB Ma5), infectious bursal disease virus (e.g., Nobilis
Gumboro D78, Innovax-ND-IBD) and avian reovirus (e.g., Nobilis Reo 1133, Nobilis
Multriva REOm). The vaccine should be given at least 4 weeks after administration of
the primary vaccination.
For intramuscular use.
Administer a single dose of 0.3 ml in the breast or thigh region from 8 weeks of age
onwards, but no later than 4 weeks before the onset of lay.
Before use allow the vaccine to reach room temperature.
Shake well before use.
Syringes and needles must be sterile before use.
Follow standard aseptic procedures.
When primary vaccinations were performed against avian metapneumovirus (e.g.,
Nobilis Rhino CV) and/or Newcastle disease virus (e.g., Nobilis ND C2, Nobilis ND
Clone 30, Innovax-ND-IBD), the vaccine should be given at least 4 weeks after
administration of the primary vaccination.

None.

Chickens:
Uncommon (1 to 10 animals /
1,000 animals treated):
Injection site lump
1
Generally disappearing within 3 weeks. Maximum size of the swelling up to 3 cm in
diameter.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or the national competent authority via the
national reporting system. See the package leaflet for respective contact details.

Vaccinate healthy animals only.

Special precautions for safe use in the target species:
Not applicable.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
To the user:
This veterinary medicinal product contains mineral oil. Accidental injection/self-
injection may result in severe pain and swelling, particularly if injected into a joint or
finger, and in rare cases could result in the loss of the affected finger if prompt
medical attention is not given. If you are accidentally injected with this veterinary
medicinal product, seek prompt medical advice even if only a very small amount is
injected and take the package leaflet with you. If pain persists for more than 12 hours
after medical examination, seek medical advice again.
To the physician:
This veterinary medicinal product contains mineral oil. Even if small amounts have
been injected, accidental injection with this veterinary medicinal product can cause
intense swelling, which may, for example, result in ischaemic necrosis and even the
loss of a digit. Expert, PROMPT, surgical attention is required and may necessitate
early incision and irrigation of the injected area, especially where there is involvement
of finger pulp or tendon.
Special precautions for the protection of the environment:
Not applicable.

No information is available on the safety and efficacy of this vaccine when used with
any other veterinary medicinal product. A decision to use this vaccine before or after
any other veterinary medicinal product therefore needs to be made on a case-by-
case basis.

Store in a refrigerator (2 C – 8 C).
Do not freeze.
Protect from direct sunlight.

Zero days.

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.